Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 240.00 | |
5 mg | In stock | $ 600.00 | |
10 mg | In stock | $ 855.00 | |
25 mg | In stock | $ 1,280.00 | |
50 mg | In stock | $ 1,750.00 | |
100 mg | In stock | $ 2,360.00 | |
500 mg | In stock | $ 4,730.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 776.00 |
Description | Setrobuvir (ANA-598) is an orally active non-nucleoside HCV NS5B polymerase inhibitor with inhibitory effects on de novo RNA synthesis and primer extension with IC50s between 4 and 5 nM. setrobuvir shows good binding affinity for SARS-CoV-2 RdRp and induces inhibition of RdRp. |
Targets&IC50 | RNA synthesis and primer extension:4~5 nM |
In vivo | Setrobuvir (200, 400, and 800 mg) BID were -2.1, -2.2, and -2.9 log10 IU/mL, respectively (vs ≤0.1 log10 IU/mL with placebo).[3] |
Synonyms | RO-5466731, ANA-598, RG7790, ANA598, RG-7790 |
Molecular Weight | 560.62 |
Formula | C25H25FN4O6S2 |
CAS No. | 1071517-39-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.61 mg/mL (10 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Setrobuvir 1071517-39-9 Cell Cycle/Checkpoint DNA Damage/DNA Repair Microbiology/Virology Proteases/Proteasome SARS-CoV HCV Protease DNA/RNA Synthesis RO5466731 RO-5466731 ANA-598 RG7790 RO 5466731 ANA 598 ANA598 RG-7790 RG 7790 inhibitor inhibit